Found: 6
Select item for more details and to access through your institution.
Impact of hepatitis C virus recombinant form RF1_2k/1b on treatment outcomes within the Georgian national hepatitis C elimination program.
- Published in:
- Hepatology Research, 2018, v. 48, n. 1, p. 36, doi. 10.1111/hepr.12890
- By:
- Publication type:
- Article
High incidence of the hepatitis C virus recombinant 2k/1b in Georgia: Recommendations for testing and treatment.
- Published in:
- Hepatology Research, 2015, v. 45, n. 13, p. 1292, doi. 10.1111/hepr.12505
- By:
- Publication type:
- Article
Etiologic Agents of Central Nervous System Infections among Febrile Hospitalized Patients in the Country of Georgia.
- Published in:
- PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0111393
- By:
- Publication type:
- Article
The natural history of recent hepatitis C virus infection among blood donors and injection drug users in the country of Georgia.
- Published in:
- Virology Journal, 2016, v. 13, n. 1, p. 1, doi. 10.1186/s12985-016-0478-6
- By:
- Publication type:
- Article
Hospital-Based Surveillance for Infectious Etiologies among Patients with Acute Febrile Illness in Georgia, 2008-2011.
- Published in:
- American Journal of Tropical Medicine & Hygiene, 2016, v. 94, n. 1, p. 236, doi. 10.4269/ajtmh.15-0400
- By:
- Publication type:
- Article
Procalcitonin as a marker of bacterial sepsis in immunocompromised patients.
- Published in:
- 2012
- By:
- Publication type:
- Abstract